ARTICLE | Company News
Zarix licenses Chiron antifungal
February 1, 2001 8:00 AM UTC
CHIR granted Zarix (Berwyn, Penn.) exclusive worldwide rights to develop and market rM-CSF recombinant human macrophage colony stimulating factor in the fields of infectious diseases and cancer. CHIR ...